185 related articles for article (PubMed ID: 12393039)
1. Globus sensation caused by gastroesophageal reflux disease.
Tokashiki R; Yamaguchi H; Nakamura K; Suzuki M
Auris Nasus Larynx; 2002 Oct; 29(4):347-51. PubMed ID: 12393039
[TBL] [Abstract][Full Text] [Related]
2. Effect of antisecretory therapy on atypical symptoms in gastroesophageal reflux disease.
Dore MP; Pedroni A; Pes GM; Maragkoudakis E; Tadeu V; Pirina P; Realdi G; Delitala G; Malaty HM
Dig Dis Sci; 2007 Feb; 52(2):463-8. PubMed ID: 17211695
[TBL] [Abstract][Full Text] [Related]
3. Belching: dyspepsia or gastroesophageal reflux disease?
Lin M; Triadafilopoulos G
Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558
[TBL] [Abstract][Full Text] [Related]
4. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
5. Globus sensation and gastroesophageal reflux.
Chevalier JM; Brossard E; Monnier P
Eur Arch Otorhinolaryngol; 2003 May; 260(5):273-6. PubMed ID: 12750918
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease.
Ribolsi M; Cicala M; Zentilin P; Neri M; Mauro A; Efthymakis K; Petitti T; Savarino V; Penagini R
Aliment Pharmacol Ther; 2018 Nov; 48(10):1074-1081. PubMed ID: 30294924
[TBL] [Abstract][Full Text] [Related]
7. Silent reflux: ex juvantibus criteria for diagnosis and treatment of laryngeal disorders.
Monini S; Di Stadio A; Vestri A; Barbara M
Acta Otolaryngol; 2006 Aug; 126(8):866-71. PubMed ID: 16846931
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficiency of two different proton pump inhibitor formula in treatment of patients with atypical gastroesophageal reflux disease: a prospective randomized study.
Lin XH; Luo JC; Ting PH; Chang TE; Huang YH; Hou MC; Lee FY
J Gastroenterol Hepatol; 2020 Dec; 35(12):2096-2102. PubMed ID: 32401385
[TBL] [Abstract][Full Text] [Related]
9. Is the proton pump inhibitor test helpful in patients with laryngeal symptoms?
Kim JH; Sung IK; Hong SN; Lee SY; Park HS; Shim CS
Dig Dis Sci; 2013 Jun; 58(6):1663-7. PubMed ID: 23443492
[TBL] [Abstract][Full Text] [Related]
10. [A study of extraesophageal presentations in gastroesophageal reflux disease].
Li ZS; Xu XR; Zou DW; Xie WF; Yu XF; Chen XM; Lin Y; Xia J; Zhu FS; Wen W; Su T
Zhonghua Nei Ke Za Zhi; 2006 Jan; 45(1):13-6. PubMed ID: 16624080
[TBL] [Abstract][Full Text] [Related]
11. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
[TBL] [Abstract][Full Text] [Related]
12. [Impact of 24-hour intraesophageal pH monitoring with 2 channels in the diagnosis of reflux-induced otolaryngologic disorders].
Issing WJ; Tauber S; Folwaczny C; Reichel O
Laryngorhinootologie; 2003 May; 82(5):347-52. PubMed ID: 12800080
[TBL] [Abstract][Full Text] [Related]
13. Diaphragmatic Breathing Reduces Belching and Proton Pump Inhibitor Refractory Gastroesophageal Reflux Symptoms.
Ong AM; Chua LT; Khor CJ; Asokkumar R; S/O Namasivayam V; Wang YT
Clin Gastroenterol Hepatol; 2018 Mar; 16(3):407-416.e2. PubMed ID: 29104130
[TBL] [Abstract][Full Text] [Related]
14. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
15. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
Azzam RS
Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitor after endoscopic resection for esophageal squamous cell cancer: multicenter prospective randomized controlled trial.
Kakushima N; Hori K; Ono H; Horimatsu T; Uedo N; Ohata K; Doyama H; Kaneko K; Oda I; Hikichi T; Kawahara Y; Niimi K; Takaki Y; Mizuno M; Yazumi S; Hosokawa A; Imagawa A; Niimi M; Yoshimura K; Muto M
J Gastroenterol; 2016 Feb; 51(2):104-11. PubMed ID: 25940151
[TBL] [Abstract][Full Text] [Related]
17. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
Pace F; Pace M
Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016
[TBL] [Abstract][Full Text] [Related]
18. The clinical characteristics of gastroesophageal reflux disease in patients with laryngeal symptoms who are referred to gastroenterology.
Oh JH; Choi MG; Park JM; Lim CH; Cho YK; Lee IS; Kim SW; Chung IS
Dis Esophagus; 2013 Jul; 26(5):465-9. PubMed ID: 22816650
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of and impact of pantoprazole on nocturnal heartburn and associated sleep complaints in patients with erosive esophagitis.
Kindt S; Imschoot J; Tack J
Dis Esophagus; 2011 Nov; 24(8):531-7. PubMed ID: 21418126
[TBL] [Abstract][Full Text] [Related]
20. [Clinical Review of Globus Patients with a Focus on GERD Cases].
Uno K; Saito K; Yabe H; Kono T; Ogawa K
Nihon Jibiinkoka Gakkai Kaiho; 2016 Nov; 119(11):1388-96. PubMed ID: 30035518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
